Literature DB >> 19848414

Assembly of hybrid bacteriophage Qbeta virus-like particles.

Steven D Brown1, Jason D Fiedler, M G Finn.   

Abstract

Bacteriophage Qbeta coat protein forms uniform virus-like particles when expressed recombinantly in a variety of organisms. We have inserted the IgG-binding Z domain at the carboxy terminus of the coat protein and coexpressed this chimeric subunit with native coat protein to create hybrid, IgG-binding virus-like particles. Extracellular osmolytes were found to have an effect on the efficiency of incorporation of fusion proteins into VLPs in Escherichia coli when a carbenicillin, but not a kanamycin, selection marker was used. The addition of sucrose to the growth medium decreased the incorporation efficiency; the osmoprotectant glycine betaine eliminated this effect. The decrease in efficiency was not observed when carbenicillin was omitted from the final expression culture. The addition of sodium chloride instead of sucrose gave rise to particles with a larger number of fusion proteins than the standard conditions. These results illustrate that cellular conditions should be taken into account even in apparently simple systems when natural or engineered protein nanoparticles are made.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19848414      PMCID: PMC2799296          DOI: 10.1021/bi901306p

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  RNA bacteriophage capsid-mediated drug delivery and epitope presentation.

Authors:  William L Brown; Robert A Mastico; Min Wu; Karen G Heal; Chris J Adams; James B Murray; Jeremy C Simpson; J Michael Lord; Andrew W Taylor-Robinson; Peter G Stockley
Journal:  Intervirology       Date:  2002       Impact factor: 1.763

2.  Targeting of adenovirus via genetic modification of the viral capsid combined with a protein bridge.

Authors:  Nikolay Korokhov; Galina Mikheeva; Alexander Krendelshchikov; Natalya Belousova; Vera Simonenko; Valentina Krendelshchikova; Alexander Pereboev; Alexander Kotov; Olga Kotova; Pierre L Triozzi; Wayne A Aldrich; Joanne T Douglas; Kin-Ming Lo; Papia T Banerjee; Stephen D Gillies; David T Curiel; Victor Krasnykh
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

3.  Cross-dressing the virion: the transcapsidation of adeno-associated virus serotypes functionally defines subgroups.

Authors:  Joseph E Rabinowitz; Dawn E Bowles; Susan M Faust; Julie G Ledford; Scott E Cunningham; R Jude Samulski
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  A synthetic IgG-binding domain based on staphylococcal protein A.

Authors:  B Nilsson; T Moks; B Jansson; L Abrahmsén; A Elmblad; E Holmgren; C Henrichson; T A Jones; M Uhlén
Journal:  Protein Eng       Date:  1987 Feb-Mar

5.  Virus stability and protein-nucleic acid interaction as studied by high-pressure effects on nodaviruses.

Authors:  W D Schwarcz; S P C Barroso; A M O Gomes; J E Johnson; A Schneemann; A C Oliveira; J L Silva
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2004-06       Impact factor: 1.770

6.  Mechanism of capsid assembly for an icosahedral plant virus.

Authors:  A Zlotnick; R Aldrich; J M Johnson; P Ceres; M J Young
Journal:  Virology       Date:  2000-11-25       Impact factor: 3.616

7.  Protein production by auto-induction in high density shaking cultures.

Authors:  F William Studier
Journal:  Protein Expr Purif       Date:  2005-05       Impact factor: 1.650

8.  Osmoregulatory systems of Escherichia coli: identification of betaine-carnitine-choline transporter family member BetU and distributions of betU and trkG among pathogenic and nonpathogenic isolates.

Authors:  Anh Ly; James Henderson; Annie Lu; Doreen E Culham; Janet M Wood
Journal:  J Bacteriol       Date:  2004-01       Impact factor: 3.490

9.  SOS response induction by beta-lactams and bacterial defense against antibiotic lethality.

Authors:  Christine Miller; Line Elnif Thomsen; Carina Gaggero; Ronen Mosseri; Hanne Ingmer; Stanley N Cohen
Journal:  Science       Date:  2004-08-12       Impact factor: 47.728

10.  Adeno-associated virus type 2 VP2 capsid protein is nonessential and can tolerate large peptide insertions at its N terminus.

Authors:  Kenneth H Warrington; Oleg S Gorbatyuk; Jeffrey K Harrison; Shaun R Opie; Sergei Zolotukhin; Nicholas Muzyczka
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

View more
  26 in total

1.  Multivalent display and receptor-mediated endocytosis of transferrin on virus-like particles.

Authors:  Deboshri Banerjee; Allen P Liu; Neil R Voss; Sandra L Schmid; M G Finn
Journal:  Chembiochem       Date:  2010-06-14       Impact factor: 3.164

2.  Cell targeting with hybrid Qβ virus-like particles displaying epidermal growth factor.

Authors:  Jonathan K Pokorski; Marisa L Hovlid; M G Finn
Journal:  Chembiochem       Date:  2011-09-29       Impact factor: 3.164

3.  A potential nanobiotechnology platform based on infectious bursal disease subviral particles.

Authors:  Omid Taghavian; Manoj K Mandal; Nicole F Steinmetz; Stefan Rasche; Holger Spiegel; Rainer Fischer; Stefan Schillberg
Journal:  RSC Adv       Date:  2012-01-09       Impact factor: 3.361

4.  Development of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo.

Authors:  Lingjun Zhang; Wen Qiu; Stephen Crooke; Yan Li; Areeba Abid; Bin Xu; M G Finn; Feng Lin
Journal:  ACS Chem Biol       Date:  2017-01-12       Impact factor: 5.100

5.  Making Conjugation-induced Fluorescent PEGylated Virus-like Particles by Dibromomaleimide-disulfide Chemistry.

Authors:  Zhuo Chen; Stacey T Detvo; Elizabeth Pham; Jeremiah J Gassensmith
Journal:  J Vis Exp       Date:  2018-05-27       Impact factor: 1.355

6.  Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization.

Authors:  Jonathan K Pokorski; Kurt Breitenkamp; Lars O Liepold; Shefah Qazi; M G Finn
Journal:  J Am Chem Soc       Date:  2011-05-31       Impact factor: 15.419

7.  Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.

Authors:  Simone Grasso; Luca Santi
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2010-07-06

Review 8.  Biomolecular Assemblies: Moving from Observation to Predictive Design.

Authors:  Corey J Wilson; Andreas S Bommarius; Julie A Champion; Yury O Chernoff; David G Lynn; Anant K Paravastu; Chen Liang; Ming-Chien Hsieh; Jennifer M Heemstra
Journal:  Chem Rev       Date:  2018-10-03       Impact factor: 60.622

9.  Biodegradable Viral Nanoparticle/Polymer Implants Prepared via Melt-Processing.

Authors:  Parker W Lee; Sourabh Shukla; Jaqueline D Wallat; Chaitanya Danda; Nicole F Steinmetz; Joao Maia; Jonathan K Pokorski
Journal:  ACS Nano       Date:  2017-09-13       Impact factor: 15.881

10.  Engineered mutations change the structure and stability of a virus-like particle.

Authors:  Jason D Fiedler; Cody Higginson; Marisa L Hovlid; Alexander A Kislukhin; Alexandra Castillejos; Florian Manzenrieder; Melody G Campbell; Neil R Voss; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-25       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.